CVS Health Corporation (FRA:CVS)
Germany · Delayed Price · Currency is EUR | Market Cap | 90.70B |
| Revenue (ttm) | 327.26B |
| Net Income (ttm) | 3.86B |
| Shares Out | n/a |
| EPS (ttm) | 3.06 |
| PE Ratio | 23.51 |
| Forward PE | 12.42 |
| Dividend | 2.40 (3.39%) |
| Ex-Dividend Date | Jul 22, 2025 |
| Volume | 30 |
| Average Volume | 129 |
| Open | 70.81 |
| Previous Close | 70.73 |
| Day's Range | 70.81 - 71.43 |
| 52-Week Range | 41.94 - 71.43 |
| Beta | n/a |
| RSI | 71.20 |
| Earnings Date | Oct 29, 2025 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
What Does the Market Think About CVS Health Corp?
CVS Health Corp's (NYSE: CVS) short interest as a percent of float has fallen 19.68% since its last report. According to exchange reported data, there are now 18.94 million shares sold short , which ...
CVS or HQY: Which Is the Better Value Stock Right Now?
CVS vs. HQY: Which Stock Is the Better Value Option?
Ex-Dividend Reminder: Thor Industries, CVS Health and Dynex Capital
Looking at the universe of stocks we cover at Dividend Channel, on 10/23/25, Thor Industries, Inc. (Symbol: THO), CVS Health Corporation (Symbol: CVS), and Dynex Capital Inc (Symbol: DX) will all trad...
Insider trades: CVS Health, Fastenal among major names this week
A weekly overview of insider trading, highlighting significant purchases and sales by investors, directors, and executives.
CVS Pharmacy Says It Gained 9 Million Former Rite Aid Customers
CVS Pharmacy said it is now serving more than 9 million former Rite Aid and Bartell Drugs patients after completing its acquisition of select assets of the now-closed Rite Aid.
CVS Enhances Access to Fertility Treatments Through New Initiative
CVS Enhances Access to Fertility Treatments Through New Initiative
CVS Health (CVS) Completes Acquisition of Rite Aid Assets to Expand U.S. Presence
CVS Health (CVS) Completes Acquisition of Rite Aid Assets to Expand U.S. Presence
CVS closes on deal to add Rite Aid assets
CVS to Enhance Accessibility to Affordable Fertility Treatments
CVS to Enhance Accessibility to Affordable Fertility Treatments
CVS INVESTIGATION: Bragar Eagel & Squire, P.C. Continues Investigation into CVS Health Corporation on Behalf of Long-Term Stockholders and Urges Investors to Contact the Firm
CVS allegedly misled investors on its Health Care Benefits segment; rising medical costs and poor forecasts led to repeated guidance cuts and stock drops.
CVS Health Helps Improve Access to More Affordable Fertility Treatments
WOONSOCKET, R.I. , Oct. 16, 2025 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced it will support simpler access to more affordable fertility treatments for all Americans through its CVS Special...
Should You Add CVS Health Stock to Your Portfolio Before Q3 Earnings?
CVS Health prepares Q3 results, with pharmacy performance and Aetna's progress in focus for investors.
Here's Why CVS Health (CVS) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights include StoneCo, PagSeguro Digital, KT, Arrow Electronics and CVS Health
Zacks spotlights StoneCo, PagSeguro Digital, KT, Arrow Electronics, and CVS Health as attractive low price-to-book stocks with strong growth prospects.
Zacks.com featured highlights include Hasbro, Peloton Interactive, Carvana, CVS Health and Kinross Gold
Zacks highlights Hasbro, Peloton Interactive, Carvana, CVS Health, and Kinross Gold as top-ranked stocks poised for potential earnings beats this season.
CVS Factor-Based Stock Analysis
Below is Validea's guru fundamental report for CVS HEALTH CORP (CVS). Of the 22 guru strategies we follow, CVS rates highest using our Multi-Factor Investor model based on the published strategy of Pi...
CVS Health Completes Purchase Of Rite Aids, Adds 9 Million Customers
CVS Health has completed the acquisition of 63 Rite Aid stores in Idaho, Oregon and Washington and prescription files across 15 states that served more than 9 million customers, the drugstore chain sa...
CVS Acquires Rite Aid Assets to Expand Nationwide Presence
CVS Acquires Rite Aid Assets to Expand Nationwide Presence
CVS Pharmacy completes acquisition of Rite Aid assets nationwide
Company wraps up conversion of 63 former Rite Aid and Bartell Drugs stores in the Pacific Northwest and hundreds of prescription file buys across 15 states WOONSOCKET, R.I. , Oct. 15, 2025 /PRNewswire...
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
Top-ranked stocks Hasbro (HAS), Peloton Interactive (PTON), Carvana (CVNA), CVS Health (CVS) and Kinross Gold (KGC) are likely to beat on the bottom line in their upcoming releases.
CVS Health (CVS) Sees Analyst Raise Price Target to $89 | CVS Stock News
CVS Health (CVS) Sees Analyst Raise Price Target to $89 | CVS Stock News
Goldman Sachs Initiates Coverage on CVS Health with a Buy Rating | CVS Stock News
Goldman Sachs Initiates Coverage on CVS Health with a Buy Rating | CVS Stock News
CVS Health® 2025 Rx Report highlights transformation of community pharmacy to meet patient needs
CVS Health/Morning Consult survey reveals patients trust and prefer local pharmacy care, want expanded services in community pharmacy Number of pharmacy technicians who want to become pharmacists has ...
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.
Deal Dispatch: Confluent Considers Sale, Rothschild Exits The Economist, CVS Feels The Pain
New On The Block Confluent Inc. (NASDAQ: CFLT), a California-based data streaming company, is exploring a potential sale after drawing interest from several private equity firms and tech companies. A...